|
|
Volumn 12, Issue 4, 2001, Pages 431-432
|
|
Management of carcinoma of unknown primary site (CUP), any changes?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
GEMCITABINE;
IMATINIB;
IRINOTECAN;
MYC PROTEIN;
PACLITAXEL;
PROTEIN BCL 2;
PROTEIN P53;
TRASTUZUMAB;
ADENOCARCINOMA;
CARCINOMA;
CLINICAL STUDY;
CONTROLLED STUDY;
DRUG EFFICACY;
EDITORIAL;
GASTROINTESTINAL TUMOR;
GENE OVEREXPRESSION;
HEAD AND NECK TUMOR;
HISTOPATHOLOGY;
HUMAN;
LARGE INTESTINE TUMOR;
METASTASIS;
ONCOGENE C ERB;
ONCOGENE C MYC;
ONCOGENE NEU;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
STOMACH CANCER;
TUMOR DIFFERENTIATION;
TUMOR LOCALIZATION;
ADENOCARCINOMA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA;
HUMANS;
NEOPLASMS, UNKNOWN PRIMARY;
|
|
EID: 0034998385
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1011192414615 Document Type: Editorial |
|
Times cited : (3)
|
|
References (11)
|
